论文信息 - S821 NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: 2-YEAR EXTENDED FOLLOW-UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY - 字舞流文

S821 NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: 2-YEAR EXTENDED FOLLOW-UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY

K. Savage | S. Ansell | P. Armand | M. Provencio | C. Sillaber | M. Trněný | W. Willenbacher | R. Ramchandren | H. Lee | T. Feldman | E. Domingo-Domènech | A. Rueda | Jonathon B. Cohen | A. Sumbul | M. Sacchi